<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Shri Balaji Valve Components Ltd. (SBVCL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/sbvcl/</link>
    <atom:link href="https://tipsheet.markets/company/sbvcl/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Shri Balaji Valve Components Ltd. (SBVCL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Tue, 28 Jul 2026 14:38:35 GMT</lastBuildDate>
    <item>
      <title>Shri Balaji Valve grows 19.5%, but customer concentration jumps to 65%</title>
      <link>https://tipsheet.markets/sbvcl-shri-balaji-valve-grows-19-5-but-customer-concentration-jumps-to-65-109261/</link>
      <guid isPermaLink="true">https://tipsheet.markets/sbvcl-shri-balaji-valve-grows-19-5-but-customer-concentration-jumps-to-65-109261/</guid>
      <pubDate>Wed, 17 Jun 2026 15:57:30 GMT</pubDate>
      <description>FY26 PAT jumped 32% to ₹8.56 crore, but top-five clients now cover 60-65% of revenue, up from 35%, and a new facility plan was downgraded to &#39;brainstorming&#39;.</description>
      <content:encoded><![CDATA[<p><em>FY26 PAT jumped 32% to ₹8.56 crore, but top-five clients now cover 60-65% of revenue, up from 35%, and a new facility plan was downgraded to 'brainstorming'.</em></p>
<h3>What’s new</h3><ul><li>Revenue up 19.5% to ₹96.81 cr, PAT up 32% to ₹8.56 cr.</li><li>Top-five customer share jumped from 35% to 60-65%; new facility plan walked back to 'brainstorming'.</li><li>Exports at 27% with a five-year 50-50 target; defence and pharma pilot orders expected next year.</li></ul>
<h3>Why it matters</h3><p>The growth is real, but the near-doubling of customer concentration in a single year and the sudden vagueness on the new plant erode predictability. At 11x P/E and a ₹94 cr market cap, the stock prices in a growth story that management's latest commentary has partly undermined.</p>
<h3>What we’re watching</h3><ul><li>Whether top-customer concentration stabilises or creeps higher.</li><li>Any concrete timeline for the new facility.</li><li>Defence and pharma order wins as potential diversification catalysts.</li></ul>
<h3>The full read</h3><p>Shri Balaji Valve closed FY26 with <strong>19.5%</strong> revenue growth to <strong>₹96.81 crore</strong> and a <strong>32%</strong> PAT jump to <strong>₹8.56 crore</strong>. The headline is healthy. But two disclosures in the call summary shift the narrative. First, the top five customers now account for <strong>60-65%</strong> of revenue — up from <strong>35%</strong> previously cited. That is a sharp increase in counterparty risk. Second, management walked back the new-facility plan from active capex to 'brainstorming'. Peak capacity of <strong>₹140-150 crore</strong> is a target, not a timeline. Exports at <strong>27%</strong> have a five-year target of <strong>50-50</strong> domestic-export mix, and pilot orders in defence and pharma are expected only next year. The <strong>₹94 crore</strong> market cap and <strong>11x</strong> P/E reflect a growth stock. But the concentration jump and facility rollback add uncertainty that the valuation hasn't priced in yet.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544074&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=SBVCL">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Shri Balaji Valve posts 32% PAT growth, sets 20-25% target for FY27</title>
      <link>https://tipsheet.markets/sbvcl-shri-balaji-valve-posts-32-pat-growth-sets-20-25-target-for-fy27-106095/</link>
      <guid isPermaLink="true">https://tipsheet.markets/sbvcl-shri-balaji-valve-posts-32-pat-growth-sets-20-25-target-for-fy27-106095/</guid>
      <pubDate>Sat, 06 Jun 2026 09:26:41 GMT</pubDate>
      <description>A routine half-year update confirms profit is expanding. Management set a growth target for next year, but nothing new emerged from the call.</description>
      <content:encoded><![CDATA[<p><em>A routine half-year update confirms profit is expanding. Management set a growth target for next year, but nothing new emerged from the call.</em></p>
<h3>What’s new</h3><ul><li>H2FY26 results show 19.5% revenue growth and 31.6% PAT growth.</li><li>Management guided for 20-25% revenue growth in FY27.</li><li>The concall included capacity details but no major new announcements.</li></ul>
<h3>Why it matters</h3><p>The numbers are solid but unsurprising. The concall's main contribution is the explicit FY27 guidance, which gives the market a concrete benchmark to measure the company against in the coming quarters.</p>
<h3>What we’re watching</h3><ul><li>Execution against the 20-25% revenue growth target.</li><li>How the company utilizes its existing capacity.</li><li>Any movement in margins as revenue scales.</li></ul>
<h3>The full read</h3><p>Shri Balaji Valve Components closed H2FY26 with <strong>19.5% revenue growth</strong> and <strong>31.6% PAT growth</strong>. A solid half. The earnings call itself was a standard review, adding little beyond the numbers. Management laid out a <strong>20-25% revenue growth</strong> target for FY27. That’s the new data point. The rest, including capacity commentary, was procedural. For a stock in the industrial components space, the result is steady execution with a forward target now in the open. Hardly a rerating event. What matters from here is whether the company can hit the guidance it just put on the table.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544074&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=SBVCL">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Shri Balaji targets 20-25% growth for FY27 on new German wins and plant capacity.</title>
      <link>https://tipsheet.markets/sbvcl-shri-balaji-targets-20-25-growth-for-fy27-on-new-german-wins-and-plant-capacity-105473/</link>
      <guid isPermaLink="true">https://tipsheet.markets/sbvcl-shri-balaji-targets-20-25-growth-for-fy27-on-new-german-wins-and-plant-capacity-105473/</guid>
      <pubDate>Thu, 04 Jun 2026 17:04:21 GMT</pubDate>
      <description>The Pune valve maker&#39;s third plant gives it headroom to ₹150 cr without new capex. A fresh German commitment and a pilot deal for a second client anchor the export push.</description>
      <content:encoded><![CDATA[<p><em>The Pune valve maker's third plant gives it headroom to ₹150 cr without new capex. A fresh German commitment and a pilot deal for a second client anchor the export push.</em></p>
<h3>What’s new</h3><ul><li>Set a FY27 growth target of 20-25%, with its new plant scaling capacity to ₹150 cr.</li><li>Landed an annual commitment from one German client and a pilot order from a second in the power sector.</li><li>Exports now cover 14 countries and are 26% of revenue, despite some Middle East logistical snags.</li></ul>
<h3>Why it matters</h3><p>The growth target is backed by tangible capacity. With the third plant commissioned, Shri Balaji has the physical headroom to add roughly ₹53 cr in sales before needing to spend heavily again. The German client wins are the first concrete evidence that the export push is converting.</p>
<h3>What we’re watching</h3><ul><li>Whether the pilot order with the second German client converts to a full annual commitment.</li><li>How raw material volatility impacts the 17% EBITDA margin target through FY27.</li><li>The pace of order flow to see if the 20-25% growth target is met or exceeded.</li></ul>
<h3>The full read</h3><p>Shri Balaji Valve Components is guiding for <strong>20-25%</strong> revenue growth in FY27, anchored by a new production line that has lifted its capacity ceiling to <strong>₹150 cr</strong>. That is about 55% above its FY26 topline of <strong>₹96.8 cr</strong>, giving the company significant runway without further major capex. The growth is starting to take shape in Europe. A German client has signed an annual commitment, and a second German firm in the power sector has placed a pilot order. Management expects to ship within six months. Exports now generate <strong>26%</strong> of revenue across 14 markets. The capacity is there. The orders are beginning to arrive. The next test is execution.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544074&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=SBVCL">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>